To help pharmaceutical manufacturers to comply with DSCSA Saleable Returns requirements and learn how Smith Drug Company resolves saleable returns verification issues (specifically the negative verification responses), LSPediA now has…
Read More
Recent Posts
Subscribe to the LSPediA Newsletter
LSPediA Shapes the Future of Pharmaceutical Serialization with OneScan 4.0 Release
Heather Sabitov Joins LSPediA Leadership Team
Smith Drug Investigator Pilot Webcast
AmerisourceBergen Investigator Pilot Webcast
LSPediA COVID-19 Advisory and Support
LSPediA Presents at HDA DMC
LSPediA Completes the FDA DSCSA Pilot Program Project
The 2020 DSCSA Headquarters: The New LSPediA.com